FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W178114350> ?p ?o ?g. }

• W178114350 endingPage "284" @default.
• W178114350 startingPage "271" @default.
• W178114350 abstract "For more than 40 years the treatment of colorectal cancer was based upon the use of 5-fluoruracil (5-FU) administered according to a variety of schedules, either alone or with several modulators. The response rate ranged between 10% and 20% with progression-free survival (PFS) of 6 months and overall survival of around 1 year. The introduction into the clinic of oxaliplatin, a diaminocyclohexane platinum analogue, and the demonstrated synergistic activity when combined with 5-FU, led to the popular scheme FOLFOX 4 and its simplified forms, including more recent evolutions with capecitabine as a substitute for leucovorin-modulated 5-FU. We learned from several randomised phase III trials that in the advanced setting these combinations could produce a response rate ranging from 37 to 50% with a progression-free survival of around 8– months. Furthermore, a small percentage of unselected patients initially considered inoperable may become resectable following chemotherapy. Oxaliplatin-based regimens can be further strengthened by the addition of a third component, either a traditional drug such as CPT11 or a targeted agent such as the anti VEGF antibody bevacizumab and the anti-EGFR receptor cetuximab. The sequential administration of all these active agents significantly improved the outcome of advanced colorectal cancer patients with several studies reporting median survivals exceeding 20 months. Two large phase III studies (the MOSAIC trial and the NSABP C07) enrolling patients with stage II and III colon cancer have consistently demonstrated a 5% absolute improvement in a 3-year DFS favouring the oxaliplatin-containing arms. In the MOSAIC trial the improved 3-year DFS translates in a statistically significant better 6-year survival only for stage III patients (73% vs. 68.6%).KeywordsOxaliplatin-based chemotherapyAdvanced colorectal cancerAdjuvant setting" @default.
• W178114350 created "2016-06-24" @default.
• W178114350 creator A5015736052 @default.
• W178114350 creator A5084410786 @default.
• W178114350 date "2009-01-01" @default.
• W178114350 modified "2023-09-25" @default.
• W178114350 title "Oxaliplatin-Based Chemotherapy for Colon Cancer" @default.
• W178114350 cites W1811602282 @default.
• W178114350 cites W1845706120 @default.
• W178114350 cites W1847661643 @default.
• W178114350 cites W1941365207 @default.
• W178114350 cites W1958418663 @default.
• W178114350 cites W1969328947 @default.
• W178114350 cites W1969825132 @default.
• W178114350 cites W1996607193 @default.
• W178114350 cites W1999974431 @default.
• W178114350 cites W2009729947 @default.
• W178114350 cites W2037339308 @default.
• W178114350 cites W2050517260 @default.
• W178114350 cites W2059006210 @default.
• W178114350 cites W2075801704 @default.
• W178114350 cites W2076366897 @default.
• W178114350 cites W2086858168 @default.
• W178114350 cites W2092215947 @default.
• W178114350 cites W2105427184 @default.
• W178114350 cites W2106845199 @default.
• W178114350 cites W2111292971 @default.
• W178114350 cites W2111837783 @default.
• W178114350 cites W2112727687 @default.
• W178114350 cites W2116539002 @default.
• W178114350 cites W2118950501 @default.
• W178114350 cites W2121368761 @default.
• W178114350 cites W2123133140 @default.
• W178114350 cites W2125328045 @default.
• W178114350 cites W2125447919 @default.
• W178114350 cites W2128403792 @default.
• W178114350 cites W2128447158 @default.
• W178114350 cites W2133399075 @default.
• W178114350 cites W2135103642 @default.
• W178114350 cites W2142564546 @default.
• W178114350 cites W2145139896 @default.
• W178114350 cites W2146798192 @default.
• W178114350 cites W2149091689 @default.
• W178114350 cites W2157416388 @default.
• W178114350 cites W2157769714 @default.
• W178114350 cites W2161563098 @default.
• W178114350 cites W2163776591 @default.
• W178114350 cites W2164906123 @default.
• W178114350 cites W2169358424 @default.
• W178114350 cites W2169946736 @default.
• W178114350 cites W2170459060 @default.
• W178114350 cites W2171232394 @default.
• W178114350 cites W2172761866 @default.
• W178114350 cites W2220367249 @default.
• W178114350 cites W2225065195 @default.
• W178114350 cites W2243460469 @default.
• W178114350 cites W2243467222 @default.
• W178114350 cites W2265393882 @default.
• W178114350 cites W2314927739 @default.
• W178114350 cites W2602544133 @default.
• W178114350 cites W3009722442 @default.
• W178114350 cites W32832981 @default.
• W178114350 cites W4238668552 @default.
• W178114350 cites W4246299175 @default.
• W178114350 doi "https://doi.org/10.1007/978-1-60327-459-3_31" @default.
• W178114350 hasPublicationYear "2009" @default.
• W178114350 type Work @default.
• W178114350 sameAs 178114350 @default.
• W178114350 citedByCount "0" @default.
• W178114350 crossrefType "book-chapter" @default.
• W178114350 hasAuthorship W178114350A5015736052 @default.
• W178114350 hasAuthorship W178114350A5084410786 @default.
• W178114350 hasConcept C121608353 @default.
• W178114350 hasConcept C126322002 @default.
• W178114350 hasConcept C143998085 @default.
• W178114350 hasConcept C2776694085 @default.
• W178114350 hasConcept C2777802072 @default.
• W178114350 hasConcept C2777909004 @default.
• W178114350 hasConcept C2778260052 @default.
• W178114350 hasConcept C2779998722 @default.
• W178114350 hasConcept C2780962732 @default.
• W178114350 hasConcept C526805850 @default.
• W178114350 hasConcept C71924100 @default.
• W178114350 hasConceptScore W178114350C121608353 @default.
• W178114350 hasConceptScore W178114350C126322002 @default.
• W178114350 hasConceptScore W178114350C143998085 @default.
• W178114350 hasConceptScore W178114350C2776694085 @default.
• W178114350 hasConceptScore W178114350C2777802072 @default.
• W178114350 hasConceptScore W178114350C2777909004 @default.
• W178114350 hasConceptScore W178114350C2778260052 @default.
• W178114350 hasConceptScore W178114350C2779998722 @default.
• W178114350 hasConceptScore W178114350C2780962732 @default.
• W178114350 hasConceptScore W178114350C526805850 @default.
• W178114350 hasConceptScore W178114350C71924100 @default.
• W178114350 hasLocation W1781143501 @default.
• W178114350 hasOpenAccess W178114350 @default.
• W178114350 hasPrimaryLocation W1781143501 @default.
• W178114350 hasRelatedWork W178114350 @default.

• next